Bold Raises $17 Million Series A to Further Accelerate Growth

by

Bold, a healthy aging platform, has secured $17 million in Series A funding led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health, Khosla Ventures, GingerBread Capital, and Primetime Partners. The company’s total funding now stands at $27 million.

Bold offers personalized, evidence-based exercise programs designed to prevent falls, reduce musculoskeletal pain and disability, and increase physical activity levels among older adults. It partners with Medicare plans and providers to support underserved members, particularly those with chronic conditions, mobility issues, and pain. The platform uses dynamic adjustments and behavioral science to engage members continuously as they build sustainable habits that lead to lasting health improvements.

In addition to expanding its partnership with national and regional Medicare plans and provider groups, Bold plans to use the funding to accelerate the growth of its clinical exercise offerings to meet the diverse physical and mental health needs of older adults.

Bold’s platform has demonstrated impressive outcomes, including a 46% reduction in falls and a 182% increase in members’ weekly physical activity levels. The company maintains a 91% member satisfaction rate, and its programs offer a >2:1 clinical return on investment in the first year for payer and provider partners.

Falls among older adults are a significant health concern, affecting more than one in four Americans over the age of 65 each year and resulting in $50 billion in costs, exceeding Medicare’s annual spending on cancer. With fewer than 15% of older adults in the U.S. meeting recommended physical activity guidelines, Bold’s approach to using movement as medicine is positioned to provide cost-effective healthspan improvements for older adults, addressing costly chronic conditions and improving overall well-being.

Bold’s mission aligns with the growing need for innovative, evidence-based solutions that support the aging population and reduce healthcare costs. The funding will help Bold continue to make a meaningful impact on the health and quality of life of older adults.

Related Stories